Targeted next-generation sequencing: microdroplet PCR approach for variant detection in research and clinical samples

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

Matthew J Huentelman acknowledges support for his work in the area of targeted next-generation resequencing from the NIH-NINDS (R01-NS059873), the Arizona Alzheimer’s Consortium and the state of Arizona, USA. He discloses that his work has been supported in part through a donation of experimental reagents from RainDance Technologies, Inc. (MA, USA) but indicates that this donation did not influence experimental design, interpretation of the data or the content of this article in any fashion. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.